Juan Rafael Munoz-Castaneda
Overview
Explore the profile of Juan Rafael Munoz-Castaneda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodelo-Haad C, Rodriguez-Ortiz M, Garcia-Saez R, Rivas-Dominguez A, Jurado-Montoya D, Martin-Malo A, et al.
Clin Kidney J
. 2025 Mar;
18(Suppl 1):i46-i60.
PMID: 40083951
The loss of kidney function entails the development of a positive phosphate balance. The burden of addressing elevated phosphate levels is high. Both parathyroid hormone (PTH) and fibroblast growth factor...
2.
Moyano-Peregrin C, Rodelo-Haad C, Martin-Malo A, Munoz-Castaneda J, Ojeda R, Lopez-Lopez I, et al.
Clin Kidney J
. 2025 Feb;
18(2):sfae390.
PMID: 39927249
Background: Serum magnesium disturbances are common in patients with cardiovascular disease (CVD). However, the well-established link between low serum magnesium and nutritional or inflammatory disorders has limited its consideration as...
3.
Pendon-Ruiz de Mier M, Santamaria R, Moyano-Peregrin C, Gordillo J, Salmoral-Chamizo A, Lopez-Lopez I, et al.
Nefrologia (Engl Ed)
. 2024 Nov;
44(5):721-730.
PMID: 39547778
Background And Objective: The progression of chronic kidney disease (CKD) involves the development of alterations in mineral metabolism that are closely related to cardiovascular outcomes and bone disease. Hypomagnesemia is...
4.
Diaz-Tocados J, Rodriguez-Ortiz M, Herencia C, Lopez-Baltanas R, Jurado-Montoya D, Garcia-Saez R, et al.
FASEB J
. 2024 Jun;
38(11):e23726.
PMID: 38847773
Calcitriol and calcimimetics are used to treat hyperparathyroidism secondary to chronic kidney disease (CKD). Calcitriol administration and the subsequent increase in serum calcium concentration decrease parathyroid hormone (PTH) levels, which...
5.
Fernandez-Villabrille S, Martin-Carro B, Martin-Virgala J, Rodriguez-Santamaria M, Baena-Huerta F, Munoz-Castaneda J, et al.
Nutrients
. 2024 Mar;
16(5).
PMID: 38474734
Bone represents a metabolically active tissue subject to continuous remodeling orchestrated by the dynamic interplay between osteoblasts and osteoclasts. These cellular processes are modulated by a complex interplay of biochemical...
6.
Lopez-Baltanas R, Rodriguez-Ortiz M, Canalejo A, Diaz-Tocados J, Herencia C, Leiva-Cepas F, et al.
Eur J Clin Invest
. 2021 Apr;
51(8):e13561.
PMID: 33870500
Background: Inflammation is a common feature in chronic kidney disease (CKD) that appears specifically associated with cardiovascular derangements in CKD patients. Observational studies have revealed a link between low Mg...
7.
Pendon-Ruiz de Mier M, Vergara N, Rodelo-Haad C, Lopez-Zamorano M, Membrives-Gonzalez C, Lopez-Baltanas R, et al.
Nutrients
. 2021 Jan;
13(2).
PMID: 33498560
In chronic kidney disease (CKD) patients, it would be desirable to reduce the intake of inorganic phosphate (P) rather than limit the intake of P contained in proteins. Urinary excretion...
8.
Rodelo-Haad C, Pendon-Ruiz de Mier M, Diaz-Tocados J, Martin-Malo A, Santamaria R, Munoz-Castaneda J, et al.
Front Cell Dev Biol
. 2020 Dec;
8:543099.
PMID: 33282857
Some of the critical mechanisms that mediate chronic kidney disease (CKD) progression are associated with vascular calcifications, disbalance of mineral metabolism, increased oxidative and metabolic stress, inflammation, coagulation abnormalities, endothelial...
9.
Carmona A, Guerrero F, Jimenez M, Ariza F, Aguera M, Obrero T, et al.
Front Cell Dev Biol
. 2020 Aug;
8:739.
PMID: 32850849
Background: Patients with chronic kidney disease (CKD) show a chronic microinflammatory state that promotes premature aging of the vascular system. Currently, there is a growth interest in the search of...
10.
Munoz-Castaneda J, Rodelo-Haad C, Pendon-Ruiz de Mier M, Martin-Malo A, Santamaria R, Rodriguez M
Toxins (Basel)
. 2020 Mar;
12(3).
PMID: 32188018
Fibroblast Growth Factor 23 (FGF23) and Klotho play an essential role in the regulation of mineral metabolism, and both are altered as a consequence of renal failure. FGF23 increases to...